Clinical Trials

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT07026474 2026-03-02

RePaIr-HN

214 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03358472 2025-12-03

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

89 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06699212 2025-10-15

ECLIPSE

412 enrolled

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03340896 2025-09-02

SALTORL

256 enrolled

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

NCT02358031 2025-07-18

MK-3475-048

882 enrolled 50 charts 2 FDA

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

NCT03840421 2025-01-13

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

468 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT04428333 2024-10-09

INDUCE-4

Phase 3 Terminated

117 enrolled 33 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06102395 2023-10-30

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

272 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02741570 2023-09-21

CheckMate 651

947 enrolled 19 charts

Head and Neck Neoplasms

NCT02940925 2023-04-12

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

241 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT05780294 2023-03-22

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

132 enrolled

Nasopharyngeal Carcinoma

NCT00274937 2022-10-25

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

111 enrolled 11 charts

Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7

NCT02383966 2022-05-13

CHANGE2

243 enrolled 17 charts

Squamous Cell Carcinoma of Head and Neck

NCT04437329 2022-05-10

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

352 enrolled

Nasopharyngeal Carcinoma

NCT02551159 2021-10-13

KESTREL

823 enrolled 23 charts

Squamous Cell Carcinoma of Head and Neck

NCT01528618 2021-10-04

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

362 enrolled

Nasopharyngeal Neoplasms

NCT00003627 2021-02-21

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx

160 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00608205 2020-08-06

Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer

69 enrolled 47 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04502641 2020-08-06

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

160 enrolled

Hypopharyngeal Neoplasms

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

562 enrolled

Nasopharyngeal Carcinoma

NCT03342352 2019-12-20

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Phase 3 Withdrawn

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03855384 2019-10-30

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

334 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00379262 2019-08-07

Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma

803 enrolled

Nasopharyngeal Carcinoma

NCT03386838 2019-04-18

An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck

Phase 3 Withdrawn

Head and Neck Neoplasms

NCT01233843 2019-01-18

2007/02

370 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00002839 2018-07-09

Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx

564 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00003888 2018-07-09

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

359 enrolled

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03503136 2018-05-11

NX-NPC

632 enrolled

Nasopharyngeal Carcinoma

NCT00117572 2018-04-09

DeCIDE

285 enrolled 22 charts

Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00995293 2018-03-02

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

240 enrolled

Head and Neck Neoplasms

NCT02500940 2015-07-17

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

54 enrolled

Nasopharyngeal Carcinoma

NCT02485548 2015-06-30

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

120 enrolled

Head and Neck Squamous Cell Cancer

NCT01177956 2014-09-03

CHANGE

73 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck

NCT00122460 2014-07-23

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

442 enrolled 18 charts

Head and Neck Neoplasms

NCT01245959 2014-02-13

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

476 enrolled

Nasopharyngeal Carcinoma

NCT00002496 2014-01-24

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00003576 2013-12-19

Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery

200 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00003637 2013-12-19

Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx

200 enrolled

Head and Neck Neoplasms

NCT00095875 2013-11-19

Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

145 enrolled 10 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00002747 2013-09-20

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

240 enrolled

Head and Neck Neoplasms

NCT00002476 2013-08-02

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00677118 2013-07-12

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

506 enrolled

Nasopharyngeal Carcinoma

NCT00113399 2013-07-02

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Phase 3 Terminated

15 enrolled 5 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00002888 2013-06-21

Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01536223 2013-03-05

ESNCCT

400 enrolled

Nasopharyngeal Carcinoma

NCT00268372 2012-10-04

S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx

Phase 3 Terminated

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00158652 2011-11-08

Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC

840 enrolled